Copyright
©The Author(s) 2020.
World J Transplant. Jul 29, 2020; 10(7): 206-214
Published online Jul 29, 2020. doi: 10.5500/wjt.v10.i7.206
Published online Jul 29, 2020. doi: 10.5500/wjt.v10.i7.206
Parameters | TEG group | CCT group | Statistical significance |
Median donor age | 49 yr (n = 17) | 38 yr (n = 51) | P = 0.16 Mann-Whitney test |
Proportion of DCD grafts, n (%) | 4 (23.53) | 12 (23.53) | P > 0.99 Fisher’s exact test |
Proportion of recipients with portal vein extension, n (%) | 3 (17.65) | 7 (13.73) | P = 0.70 Fisher’s exact test |
Proportion of recipients with prolonged cold ischemic time(> 12 h) for the pancreas graft, n (%) | 7 (41.18) | 27 (52.94) | P = 0.58 Fisher’s exact test |
Median peak serum amylase in the first two weeks after transplant | 191 IU/L | 312 IU/L | P = 0.09 Mann-Whitney test |
Median peak C-reactive protein in the first two weeks after transplant | 148.6 | 160.6 | P = 0.54 Mann-Whitney test |
- Citation: Gopal JP, Dor FJ, Crane JS, Herbert PE, Papalois VE, Muthusamy AS. Anticoagulation in simultaneous pancreas kidney transplantation - On what basis? World J Transplant 2020; 10(7): 206-214
- URL: https://www.wjgnet.com/2220-3230/full/v10/i7/206.htm
- DOI: https://dx.doi.org/10.5500/wjt.v10.i7.206